Verona Pharma plc (VRP.L) (LON:VRP) Shares Pass Below 200-Day Moving Average – Here’s Why

Verona Pharma plc (VRP.L) (LON:VRP)’s stock price passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 55 ($0.69) and traded as low as GBX 50 ($0.63). Verona Pharma plc (VRP.L) shares last traded at GBX 55 ($0.69), with a volume of 70,791 shares trading hands.

Verona Pharma plc (VRP.L) Price Performance

The company has a market cap of £228 million and a PE ratio of -1.68. The firm has a 50-day simple moving average of GBX 55 and a two-hundred day simple moving average of GBX 55. The company has a debt-to-equity ratio of 6.85, a current ratio of 2.99 and a quick ratio of 2.47.

About Verona Pharma plc (VRP.L)

Verona Pharma plc, a clinical stage biopharmaceutical company, develops and commercializes therapeutics to treat respiratory diseases. The company's product candidate is RPL554, an inhaled dual inhibitor of the enzymes phosphodiesterase 3 and 4, which has completed Phase I and II clinical trials that acts as a bronchodilator and an anti-inflammatory agent for the treatment of chronic obstructive pulmonary disease, cystic fibrosis, chronic asthma, and allergic rhinitis.